Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review

On average, there are about 300,000 new cases of brain cancer each year. Studies have shown that brain and central nervous system tumors are among the top ten causes of death. Due to the extent of this problem and the percentage of patients suffering from brain tumors, innovative therapeutic treatme...

Full description

Bibliographic Details
Main Authors: Dorota Bartusik-Aebisher, Paweł Woźnicki, Klaudia Dynarowicz, David Aebisher
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/13/9/1299
_version_ 1797581057055260672
author Dorota Bartusik-Aebisher
Paweł Woźnicki
Klaudia Dynarowicz
David Aebisher
author_facet Dorota Bartusik-Aebisher
Paweł Woźnicki
Klaudia Dynarowicz
David Aebisher
author_sort Dorota Bartusik-Aebisher
collection DOAJ
description On average, there are about 300,000 new cases of brain cancer each year. Studies have shown that brain and central nervous system tumors are among the top ten causes of death. Due to the extent of this problem and the percentage of patients suffering from brain tumors, innovative therapeutic treatment methods are constantly being sought. One such innovative therapeutic method is photodynamic therapy (PDT). Photodynamic therapy is an alternative and unique technique widely used in dermatology and other fields of medicine for the treatment of oncological and nononcological lesions. Photodynamic therapy consists of the destruction of cancer cells and inducing inflammatory changes by using laser light of a specific wavelength in combination with the application of a photosensitizer. The most commonly used photosensitizers include 5-aminolevulinic acid for the enzymatic generation of protoporphyrin IX, Temoporfin—THPC, Photofrin, Hypericin and Talaporfin. This paper reviews the photosensitizers commonly used in photodynamic therapy for brain tumors. An overview of all three generations of photosensitizers is presented. Along with an indication of the limitations of the treatment of brain tumors, intraoperative photodynamic therapy and its possibilities are described as an alternative therapeutic method.
first_indexed 2024-03-10T22:58:44Z
format Article
id doaj.art-d7dd6d1cf7e146fda3bcdaf4df8eee52
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-10T22:58:44Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-d7dd6d1cf7e146fda3bcdaf4df8eee522023-11-19T09:49:00ZengMDPI AGBrain Sciences2076-34252023-09-01139129910.3390/brainsci13091299Photosensitizers for Photodynamic Therapy of Brain Cancers—A ReviewDorota Bartusik-Aebisher0Paweł Woźnicki1Klaudia Dynarowicz2David Aebisher3Department of Biochemistry and General Chemistry, Medical College of the University of Rzeszów, 35-959 Rzeszów, PolandStudents English Division Science Club, Medical College of the University of Rzeszów, 35-959 Rzeszów, PolandCenter for Innovative Research in Medical and Natural Sciences, Medical College of the University of Rzeszów, 35-310 Rzeszów, PolandDepartment of Photomedicine and Physical Chemistry, Medical College of the University of Rzeszów, 35-959 Rzeszów, PolandOn average, there are about 300,000 new cases of brain cancer each year. Studies have shown that brain and central nervous system tumors are among the top ten causes of death. Due to the extent of this problem and the percentage of patients suffering from brain tumors, innovative therapeutic treatment methods are constantly being sought. One such innovative therapeutic method is photodynamic therapy (PDT). Photodynamic therapy is an alternative and unique technique widely used in dermatology and other fields of medicine for the treatment of oncological and nononcological lesions. Photodynamic therapy consists of the destruction of cancer cells and inducing inflammatory changes by using laser light of a specific wavelength in combination with the application of a photosensitizer. The most commonly used photosensitizers include 5-aminolevulinic acid for the enzymatic generation of protoporphyrin IX, Temoporfin—THPC, Photofrin, Hypericin and Talaporfin. This paper reviews the photosensitizers commonly used in photodynamic therapy for brain tumors. An overview of all three generations of photosensitizers is presented. Along with an indication of the limitations of the treatment of brain tumors, intraoperative photodynamic therapy and its possibilities are described as an alternative therapeutic method.https://www.mdpi.com/2076-3425/13/9/1299brain cancersphotodynamic therapymolecular targeted therapiesphotosensitizers
spellingShingle Dorota Bartusik-Aebisher
Paweł Woźnicki
Klaudia Dynarowicz
David Aebisher
Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review
Brain Sciences
brain cancers
photodynamic therapy
molecular targeted therapies
photosensitizers
title Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review
title_full Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review
title_fullStr Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review
title_full_unstemmed Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review
title_short Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review
title_sort photosensitizers for photodynamic therapy of brain cancers a review
topic brain cancers
photodynamic therapy
molecular targeted therapies
photosensitizers
url https://www.mdpi.com/2076-3425/13/9/1299
work_keys_str_mv AT dorotabartusikaebisher photosensitizersforphotodynamictherapyofbraincancersareview
AT pawełwoznicki photosensitizersforphotodynamictherapyofbraincancersareview
AT klaudiadynarowicz photosensitizersforphotodynamictherapyofbraincancersareview
AT davidaebisher photosensitizersforphotodynamictherapyofbraincancersareview